# Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer

> **NCT02330003** · PHASE1 · COMPLETED · sponsor: **Il-Yang Pharm. Co., Ltd.** · enrollment: 100 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** IL-YANG FLU Vaccine Prefilled Syringe INJ.
- **BIOLOGICAL:** Fluarix Prefilled Syringe

## Key facts

- **NCT ID:** NCT02330003
- **Lead sponsor:** Il-Yang Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2015-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02330003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02330003, "Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02330003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*